Skip to content
Home/Companies/Biotech/Neumirna Therapeutics
Neumirna Therapeutics

Neumirna Therapeutics

Biotech·Denmark·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Neumirna Therapeutics?

Neumirna Therapeutics is currently owned by Invivo Partners through Invivo Ventures III (2024 vintage), since 2025.

Hand-verified · updated 2026-08-09

Invivo Partners
Investor
Invivo Partners
Invivo Ventures III · 2024 · Life Sciences VC

Key facts

HQDenmark
SectorBiotech
StatusActive

More from Invivo Ventures III

Other portfolio companies in the same fund.

Track Neumirna Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Neumirna Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue